A Novel Triglyceride- and Cholesterol-Enriched Lipoprotein(a) Phenotype in Moderate Hypertriglyceridemia: Reversal by ApoC-III Inhibition. [PDF]
JACC Basic Transl SciLin L +6 more
europepmc +1 more source
Abetalipoproteinemia With a Novel Microsomal Triglyceride Transfer Protein Gene Mutation and Unique Oxidized Lipoprotein Levels. [PDF]
J Med CasesHamasaki M, Hara K, Kotani K.
europepmc +1 more source
Real-World Outcomes of Lipoprotein Apheresis in Homozygous Familial Hypercholesterolemia: A Single-Center Longitudinal Experience. [PDF]
J Clin MedMercan Sarıdaş F +8 more
europepmc +1 more source
Free Fatty Acids Carried by Lipoproteins: Revisiting the Overlooked Cargo. [PDF]
Acta Physiol (Oxf)Henderson GC, Buhman KK, Tomoo K.
europepmc +1 more source
Targeting Lipoprotein(a): A New Era in Cardiovascular Disease Prevention. [PDF]
Methodist Debakey Cardiovasc JBene-Alhasan Y +3 more
europepmc +1 more source
Association between non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio and hypertension in Chinese elderly: A cross-sectional study based on CHARLS. [PDF]
Medicine (Baltimore)Huang L, Qin S, Qin F, Zhang Y.
europepmc +1 more source
Metabolic and Lipoprotein Changes in Type 2 Diabetes Patients Treated with Empagliflozin. [PDF]
BiomedicinesHabeos EE +7 more
europepmc +1 more source
Lower lipoprotein(a) levels in patients with acute lacunar infarction. [PDF]
IBRO Neurosci RepChen X, Chen N, Zhu L, Huang Q, Jiang F.
europepmc +1 more source
Lipid Variability Predicts Long-Term Major Adverse Cardiovascular Events in MINOCA: A Retrospective Cohort Study. [PDF]
Int J Gen MedWang Y, Diao M.
europepmc +1 more source
Effect of pemafibrate on LDL-cholesterol properties in type 2 diabetes and hypertriglyceridemia by lipid management status: PARM-T2D post hoc analysis. [PDF]
J Diabetes InvestigKitsunai H +8 more
europepmc +1 more source